Sara T. Olalla Saad

Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy

Carolina Lanaro, Carla Fernanda Franco‐Penteado, D M Albuqueque et al. · Journal of Leukocyte Biology · 2008 · 212 citations · Full text

Follow‐up of sickle cell disease patients with priapism treated by hydroxyurea

Sara T. Olalla Saad, Camila Lajolo, Simone Cristina Olenscki Gilli et al. · American Journal of Hematology · 2004 · 81 citations · Full text

Sickle Cell Disease, Allergy, Hydroxyurea Dosage +4

Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahidrofolate reductase among patients with sickle cell disease in Brazil

Fernanda L. Andrade, Joyce Maria Annichino‐Bizzacchi, Sara T. Olalla Saad et al. · American Journal of Hematology · 1998 · 63 citations

Immunohematology, Genetic Epidemiology, Pathology +20

Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties

Sheley Gambero, Andréia A. Canalli, Fabı́ola Traina et al. · European Journal Of Haematology · 2006 · 60 citations

Increased levels of soluble ICAM‐1 in the plasma of sickle cell patients are reversed by hydroxyurea

Nicola Conran, André Fattori, Sara T. Olalla Saad et al. · American Journal of Hematology · 2004 · 52 citations